TABLE 2.
Age group and source (reference) | No. of patients | Diagnostic technique | Gold standard(s) | SE (%) | SP (%) |
---|---|---|---|---|---|
Adults | |||||
Rouby et al. (80) | 26 | Protected mini-BAL | Histopathology, lung tissue culture | 70 | 69 |
Chastre et al. (13) | 26 | PSB | Histopathology, lung tissue culture | 100 | 60 |
Fabregas et al. (30) | 25 | TBA | Histopathology, lung tissue culture | 69 | 92 |
Protected BAL | 39 | 100 | |||
BAL | 77 | 58 | |||
PSB | 62 | 75 | |||
Any invasive diagnostic technique | 85 | 50 | |||
Children | |||||
Gauvin et al. (42) | 10 | BAL (104 CFU/ml) | Expert opinion; 2/3 blinded to BAL and PSB results | 50 | 80 |
Bacterial index >5 | 78 | 86 | |||
ICB | 30 | 95 | |||
Endotracheal cultures | 90 | 40 | |||
Labenne et al. (60) | 29 | BAL (104 CFU/ml) | (i) Positive pleural fluid culture, (ii) computed tomography scan with abscess, (iii) histopathology, (iv) lung tissue culture, (v) blood and tracheal aspirate positive for same organism without other source, (vi) expert opinion; 2/3 blinded to BAL/PSB | 72 | 88 |
PSB | 69 | 95 | |||
ICB on gram stain and + BAL | 79 | 88 | |||
ICB on gram stain and + BAL and + PSB | 90 | 88 |
SE, sensitivity; SP, specificity; TBA, tracheobronchial aspirates; ICB, intracellular bacteria.